Bring on new blood and a new vision hopefully for Vivo !!!
VIVO Announces Board Changes
Monday, July 5, 2021, 7:46 AM ET
Toronto, Ontario--(Newsfile Corp. - July 5, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, today announced that John Easson, Christie Henderson, Daryl Kramp and Rick Fitzgerald (whose temporary appointment as Interim Chief Executive Officer ended as of June 30, 2021) have resigned as directors of the Company, effective immediately, and have withdrawn their nominations to be elected as directors at the annual and special meeting of the shareholders of VIVO scheduled for 11:00 a.m. (Eastern time) today.
These resignations are related to strategic differences between the departing directors and the Company's largest shareholders. The resignations are not related to the Company's financial performance, liquidity or regulatory standing, and no material impact is expected on the Company's current operations.
Ray Laflamme, President of the Company's wholly-owned subsidiary, Canna Farms Limited, and VIVO's remaining director, stated, "On behalf of VIVO, I would like to thank each of the former directors for working closely with the Company during their tenure. They have served VIVO well and their considerable contributions are very much appreciated."
The annual and special meeting will proceed as scheduled today. VIVO anticipates that an additional announcement will be made about the new composition of the board of directors following the meeting.
About VIVO Cannabis(TM)
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna FarmsTM, Beacon Medical(TM) , Fireside(TM) , and Lumina(TM) . Harvest Medicine(TM) , VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.